很少见,非常重要:在TARE治疗中异常的远端食道动脉
Ismail Dilek1, Alaaddin Nayman1, Hasan Onner2
1Departments of Radiology.
Clinical nuclear medicine
|May 14, 2025
概括
胆管癌的跨动脉放射栓塞 (TARE) 需要精确的模拟. 发现一种罕见的肝动脉变异,导致食道中意想不到的-90微球积累.
科学领域:
- 干预性放射学 干预性放射学
- 肝胆道成像 肝胆道成像
- 核医学就是核医学.
背景情况:
- 跨动脉放射栓塞 (TARE) 是肝脏恶性瘤的标准治疗方法.
- TARE涉及模拟和处理阶段,以产生-90 (Y-90) 微球.
- 准确的肝动脉解剖图是TARE成功的关键.
研究的目的:
- 报告在TARE模拟过程中遇到的罕见解剖变异.
- 为了强调TARE中详细的手术前成像的重要性.
- 为了记录潜在的并发症,源于意想不到的血管变化.
主要方法:
- 用增强对比的圆束CT进行了详细的肝动脉解剖学评估.
- 为了模拟Y-90微球分布,进行了Technetium-99m宏聚合白蛋白 (99mTc MAA) SPECT.
- 该病例涉及一名患有胆管癌的患者接受TARE治疗.
主要成果:
- 鉴定出一种罕见的源自肝动脉的远端食道动脉.
- SPECT成像证实了99mTcMAA在远端食道和胃心脏中的肝外积累.
- 这种解剖学变异在TARE期间构成意外辐射输送的风险.
结论:
- 在TARE中程序前成像对于识别罕见的解剖变异至关重要.
- 这种变化可能会导致肝脏外的无意的微球输送.
- 了解这些变异对于患者的安全性和治疗疗效至关重要.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
77
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
77
Esophageal Strictures-II: Clinical Features and Management
20
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
20
Esophageal Varices-I: Introduction
51
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
51
Esophageal Varices-II: Clinical Features and Management
31
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
31
Esophageal Perforation-II: Clinical Manifestations and Management
28
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
28
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
96
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
96


